ArticleExperimental & applied acarology2025
Vector competence and transovarial transmission of Rickettsia rickettsii in Rickettsia bellii-infected and -uninfected Amblyomma dubitatum ticks.
Article in Experimental & applied acarology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of exposure to Rickettsia bellii on reservoir competence of guinea pigs for Rickettsia rickettsiiMemorias do Instituto Oswaldo Cruz · 2026Article
- Spotted Fever Rickettsioses in Panama: New Cases and the Gaps That Hinder Its Epidemiological Understanding.Pathogens (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Brazilian spotted fever (BSF) is endemic in southeastern Brazil, where Amblyomma sculptum is the main vector incriminated in the transmission of R. rickettsii to humans. In many BSF-endemic areas capybaras are the main hosts for A. sculptum and also efficient amplifiers of R. rickettsii for this tick species. Capybaras are also primary hosts for Amblyomma dubitatum, a tick species frequently found infected by Rickettsia bellii but with no records of natural infection by R. rickettsii. The present study aimed to evaluate transovarial transmission and vector competence for R. rickettsii in A. dubitatum naturally infected and non-infected with R. bellii. For this purpose, two A. dubitatum colonies were used, one naturally infected by R. bellii, another with no R. bellii infection. Ticks from both colonies were divided into three experimental groups: group GL (ticks fed on R. rickettsii-inoculated guinea pigs in the larval stage), group GN (ticks fed on R. rickettsii-inoculated animals in the nymphal stage) and group GC (ticks never exposed to R. rickettsii). DNA samples from eight to 20 unfed nymphs and adults fed on each guinea pig, and from all engorged females at the end of oviposition, and from their respective eggs (one pool of 20-50 eggs/female) and larvae (10 larvae/female), were subjected to species-specific qPCR protocols for either R. rickettsii or R. bellii detection. Finally, larvae originating from R. rickettsii-infected females were fed on uninfected guinea pigs. In both A. dubitatum colonies, nymphs from group GL and adults from groups GL and GN were able to transmit R. rickettsii to susceptible animals, confirming vectorial competence and transstadial perpetuation of the pathogen. Further, infection by R. rickettsii was detected in eggs and larvae from 18% to 75% of GN and GL R. bellii-uninfected females, and from 25% to 44% of GN and GL R. bellii-infected females, respectively, confirming the transovarial transmission of the pathogen, regardless of R. bellii infection. Finally, larvae originating from engorged females infected with R. rickettsii were able to transmit the pathogen to susceptible animals, confirming the vectorial competence of ticks infected by transovarial transmission.
Indexed as
Identifiers
40397211What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.